Connect with us

Currax™ Holdings USA LLC Announces Launch and Close of Acquisition



Reading Time: 3 minutes

Industry veterans George Hampton and Terry Evans appointed CEO and
COO, respectively

Company to leverage enhanced capital structure to fuel organic growth
and opportunistic acquisitions

MORRISTOWN, N.J.–(BUSINESS WIRE)–Currax™ Holdings USA LLC (“the Company”) today announced its launch, in
conjunction with the closing of a strategic transaction. Currax Holdings
USA LLC is a privately held holding company that wholly owns Currax
Pharmaceuticals LLC (“Currax”) and Persion Pharmaceuticals LLC
(“Persion”), specialty pharmaceutical businesses focused on acquiring
and commercializing prescription drugs within the U.S. market.

Currax Holdings USA LLC was launched simultaneous with the completion of
its acquisition of substantially all the assets from Pernix Therapeutics
Holdings, Inc. (“Pernix”). As a result of the acquisition, Currax
Holdings USA LLC is now a portfolio company of certain funds managed by
Highbridge Capital Management, LLC (“Highbridge”). Currax now
distributes the Branded and generic medications formerly owned by
Pernix. All medications will continue to be distributed via retail
pharmacies and the Prescriptions Direct® program. Other patient support
programs including those intended to lower the out-of-pocket costs of
Currax medications will continue to be available without disruption.
Currax also owns a 10% stake in Nalpropion™ Pharmaceuticals, Inc.
(“Nalpropion”), the owner of the market leading branded weight loss
medication, Contrave®.

Currax’s enhanced capital structure will enable us to accelerate
existing portfolio medications and pursue a robust growth strategy
through acquisitions and strategic partnerships with our current
products in both Branded and generic markets,” said George Hampton,
newly appointed Chief Executive Officer of Currax Holdings USA LLC. “We
are laser focused on our broader mission to provide greater access to
life-changing medications for healthcare providers and the patients they
serve. I am delighted that our highly experienced management team will
continue on with Currax and I look forward to working with them to
accomplish our goals.”

George Hampton brings nearly three decades of industry experience to his
role as CEO of Currax Holdings USA LLC. Hampton will also serve as CEO
of Nalpropion Pharmaceuticals. Previously, he was Executive Vice
President of the Primary Care Business at Horizon Pharma (NASDAQ: HZNP),
a multi-billion dollar biopharmaceutical company. At Horizon, Hampton
reported directly to the CEO and also led the Global Orphan Business
Unit and International Operations. Across these business units, Mr.
Hampton led efforts to identify, develop, acquire and commercialize
differentiated and accessible medicines addressing unmet medical needs.

Currax Holdings USA LLC has also appointed Terry Evans Chief Operating
Officer. Mr. Evans joins the Company from Horizon Pharma, where he was
Senior Vice President and General Manager of Managed Care and Trade. He
brings over two decades of expertise in pharmaceutical distribution and

The Company will be headquartered in Morristown, NJ. More information
about Currax can be found at

Additional Information

The creation of Currax Holdings USA LLC follows the Highbridge funds’
acquisition of substantially all the assets of Pernix, including the
rights to all Branded and generic products, per the firm’s previously
disclosed “stalking-horse bid” for $75.6 million in the form of cash and
credit bid consideration. The asset purchase agreement was announced in
conjunction with Pernix’s voluntary filing for Chapter 11 protection
under the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the
District of Delaware. The transaction was completed following customary
closing conditions, including approval of the transaction by the
bankruptcy court pursuant to a motion on April 15, 2019.

Highbridge was advised by Ducera Partners LLC and Skadden, Arps, Slate,
Meagher & Flom LLP.

Pernix was advised by Guggenheim Securities, LLC, Davis Polk & Wardwell
LLP, and Ernst & Young LLP.

About Currax Holdings USA LLC

Currax Holdings USA LLC is a privately-held holding company focused on
acquiring and commercializing prescription drugs within the U.S. market.
Currax Holdings USA LLC is the parent of several subsidiaries, including
Currax Pharmaceuticals LLC and Persion Pharmaceuticals LLC, specialty
pharmaceutical businesses focused on acquiring and commercializing
prescription drugs within the US Market.


Edelman Financial Communications
Arielle Patrick

BlackRock Declares Quarterly Dividend of $3.30 on Common Stock



Reading Time: 1 minute

NEW YORK–(BUSINESS WIRE)–BlackRock, Inc. (NYSE:BLK) today announced that its Board of Directors
has declared a quarterly cash dividend of $3.30 per share of common
stock, payable June 20, 2019 to shareholders of record at the close of
business on June 6, 2019.

About BlackRock

BlackRock helps investors build better financial futures. As a fiduciary
to investors and a leading provider of financial technology, our clients
turn to us for the solutions they need when planning for their most
important goals. As of March 31, 2019, the firm managed approximately
$6.52 trillion in assets on behalf of investors worldwide. For
additional information on BlackRock, please visit
| Twitter: @blackrock | Blog:
| LinkedIn:


Investor Relations
Samantha Tortora

Media Relations
Brian Beades

Continue Reading

TechTarget Integrates 1st and 3rd Party Intent Data within Priority Engine Platform to Help Companies Make Faster Sales and Marketing Progress with Best Fit Accounts



Reading Time: 3 minutes

Enhanced account prioritization and intelligence combines
relevant TechTarget intent, fit and customer engagement data to improve
sales and marketing conversions

 (Nasdaq: TTGT), the global leader in B2B technology purchase
intent data and services today announced the release of enhanced account
rankings and insights in IT Deal Alert Priority
TM, fueled by 1st and 3rd
party purchase intent data. Marketing and sales teams will now be able
to leverage this new intelligence to get to the right accounts and
prospects faster, increasing conversions and accelerating pipeline.

“TechTarget has always focused on delivering ROI,” said Michael Cotoia,
CEO, TechTarget. “These new updates now make it even easier for our
customers to close deals faster by helping them find the prospects that
are directly in their sweet spot.”

TechTarget’s Priority Engine is a SaaS-based platform that delivers
direct access to the most active in-market accounts and fully
permissioned prospects doing purchase research in specific technology
markets. In addition to providing exclusive third-party intent insights
on the topical interests of accounts, recency and relevancy of activity,
vendor consideration and installed technologies, TechTarget is now able
to integrate multiple first-party insights, such as Ideal Customer
Profile (ICP) matching, direct engagement on a vendor’s website and
specific interactions buyers have with a customer’s content and
advertising across the TechTarget network within the platform to deliver
vastly improved account prioritization capabilities. This latest release
provides better tools for enterprise technology marketing and sales
teams to more effectively reach and engage high value accounts within
their total addressable market, including:

  • Personalized account rankings that reflect organic research
    with TechTarget AND direct engagement with the customer to improve
    marketing and sales effectiveness.
  • Ideal Customer Profile creation and filtering directly within
    Priority Engine to efficiently find, track and convert identified best
    fit customers.
  • Enhanced qualification intelligence showcases the key
    attributes that make accounts high priority targets, including: buying
    stage, ICP match and if there is a confirmed project.
  • Improved engagement signals show you precisely when accounts
    visit your website, click on your banners and/or download your content.
  • Indicators of new and recent activities give sales users new
    reasons to call and help them engage the buying team with highly
    tailored outreach.

TechTarget, named a Leader in The Forrester WaveTM: B2B
Marketing Data Providers, Q3 2018, has cemented its leadership in its
space because of the significant value and ROI its customers achieve.
TechTarget purchase intent insight is uniquely powerful because of how
it is made and how it is delivered to B2B tech marketers and sales
professionals. The actionable insights within the Priority Engine
platform are achievable because of the depth of original
decision-support content spanning 10,000 unique IT topics across
TechTarget’s network of over 140 enterprise technology-specific websites
as well as the Company’s suite of marketing and sales engagement

“Over the past six months we’ve been focused on bringing even more
actionable data into Priority Engine to help our customers more
efficiently identify and make progress with best fit accounts,” said
Andrew Briney, Senior Vice President of Products, TechTarget. “This
release marks a major milestone in these efforts and a big leap forward
for the platform.”

To learn more about Priority Engine, please or visit

About TechTarget

(Nasdaq: TTGT) is the global leader in purchase intent-driven marketing
and sales services that deliver business impact for enterprise
technology companies. By creating abundant, high-quality editorial
content across more than 140 highly targeted technology-specific
websites, TechTarget attracts and nurtures communities of technology
buyers researching their companies’ information technology needs. By
understanding these buyers’ content consumption behaviors, TechTarget
creates the purchase intent insights that fuel efficient and effective
marketing and sales activities for clients around the world.

TechTarget has offices in Boston, London, Munich, Paris, San Francisco,
Singapore and Sydney. For more information, visit
and follow us on Twitter @TechTarget.

(C) 2019 TechTarget, Inc. All rights reserved. TechTarget and the
TechTarget logo are registered trademarks and IT Deal Alert and Priority
Engine are trademarks of TechTarget. All other trademarks are the
property of their respective owners.


Media Inquiries
Garrett Mann
Director of Marketing

Continue Reading

Hines: Atlantic Natural Foods Seeks Serious Investment Partner for Flagship Brand Expansion



Reading Time: 3 minutes

Company poised for 50M+ in revenue, global product distribution

NASHVILLE, N.C.–(BUSINESS WIRE)–James Douglas Hines, founder of leading U.S. producer of shelf-stable
plant-based products and marketer Atlantic Natural Foods (ANF),
announced today that he has engaged Deloitte Corporate Finance, LLC to
assist with securing an investment partner for the rapidly growing
company. Brands in the ANF portfolio include Loma Linda® and
its award-winning plant-based seafood alterative Tuno™, neat®
and Kaffree Roma.

“Our Loma Linda meal solutions launch in 2018 saw unprecedented growth
as our products have rolled out in supermarkets and small grocery chains
across the U.S., the United Kingdom, and Australia,” Hines said. “We’re
committed to creating, manufacturing, and distributing high-quality,
sustainable plant-protein foods that are good for you and good for the
planet. We’re seeking an investment partner who shares our vision and

In just 12 months ANF has secured more than 18,000 stores worldwide and
is in process of building for the next push as it trends towards $50
Million in revenue within two years.

“ANF’s incredible growth is driven by consumer demand of sustainable
products that taste great,” Hines added. “Although vegans love our
products, we’re seeing this demand in the mainstream market, too, as
consumers of all stripes are increasingly aware of how their food
choices effect their health and environment.”

According to Hines, the explosion of plant-based protein demand is
creating a need to drastically enhance the ANF’s supply chain,
factories, finance, marketing, execution, and human and financial
capital. Currently, ANF has manufacturing locations in Nashville, NC and
Bangkok, Thailand. Both are FDA-approved facilities, Kosher-qualified,
non-GMO-assured, with SQF and BRC verification – and uphold only the
most stringent health and food safety practices.

Rory Dineen, Managing Director of Deloitte Corporate Finance LLC said,
“We are pleased to work with ANF on this investment opportunity. The
food industry is evolving and ANF’s plant-based food alternative
products offer consumers affordable and sustainable protein options.”

The United
Nations projects
that by the year 2050, the current world population
of 7.3 billion is expected to reach 9.7 billion. A number that many
scientists believe
is the breaking point for the number of people
our planet can support.

These data drive Hines, a 40-year veteran of the global food sourcing
and creation market, who wonders what food his 10 grandchildren will eat
in the future. “We can see those numbers and panic, or we can work to
ensure we create products that meet the demands of today while
delivering hope for the future. I’m excited find a partner to join us in
changing the world while delivering a high-quality, high-value, and
sustainable product.”

About Atlantic Natural Foods

Headquartered in Nashville, NC, Atlantic Natural Foods is the leading
shelf-stable manufacturer and provider of Loma Linda®, neat® and Kaffree
Roma™ brand products. Its mission is to provide affordable, sustainable
and healthy sources of plant-based protein food for all lifestyles and
people to live healthier, longer lives. The company is managed by About
All About Healthy Foods Holdings, LLC
, and operates its own
manufacturing facility in North Carolina, as well as a joint venture
project in Thailand. The brands are sold throughout the U.S. and in 17
countries, including U.K. and Australia. To learn more about Atlantic
Natural Foods visit

About Deloitte Corporate Finance LLC

Deloitte Corporate Finance LLC (DCF), a broker-dealer registered with
the U.S. Securities and Exchange Commission (SEC) and member of the Financial
Industry Regulatory Authority (FINRA)
and the Securities
Investor Protection Corporation (SIPC)
, is an indirect wholly-owned
subsidiary of Deloitte Financial Advisory Services LLP and affiliate of
Deloitte Transactions and Business Analytics LLP. Investment banking or
other services that would require registration as a broker-dealer with
the SEC and membership in FINRA would be provided exclusively by DCF.
For more information, visit
Please see
for a detailed description of the legal structure of Deloitte LLP and
its subsidiaries. Certain services may not be available to attest
clients under the rules and regulations of public accounting.


Media Contact:
Margie Newman

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us:

© 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania